20
Hetero Drugs Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Lisinopril dihydrate, Process-III, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2022-434 - Rev 00
This Chemical Type CEP, issued on May 04, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1120 associated with this CEP further emphasizes